409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Stewart, J; Strickler, J; Mettu, N; MacLaughlan, S; Niedzwiecki, D; Levine, E; Blazer, D

Published Date

  • November 2020

Published In

  • Regular and Young Investigator Award Abstracts

Published By

Digital Object Identifier (DOI)

  • 10.1136/jitc-2020-sitc2020.0409

Conference Name

  • 35th Anniversary Annual Meeting (SITC 2020)